InsidersTradesSigma
케이엠제약: directors' dealings · South Korea · DART (FSS)
DART:company-0e7cd7KR·DART (FSS)Mcap 15.0Bn€
Explore the full insider trade history of 케이엠제약, a publicly traded company based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Market capitalisation: €15bn. The latest transaction was reported on 21 April 2026 — Purchase. Among the most active insiders: 강일모. All data is accessible without an account.
8
Insider Decl.
0
Thresholds
€72,799
7 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
517.00 €
Income statement
Revenue15.99 Bn€
Gross profit3.84 Bn€24% margin
Net income−3.97 Bn€-24.8% margin
Balance sheet & cash
Market cap15.00 Bn€
Total debt15.80 Bn€
Free Cash Flow−2.01 Bn€
Last declaration on 21 April 2026
Declarations8 total
Executives●Purchase24DART
€2,98210,000 shares@ €0.29820.0000% mcap22.8% of flow
ShareKRX
DART:20260421000222·
Ideal exit: 10 Jan 2027 (T+270)
Executives●Purchase29DART
€8,72223,111 shares@ €0.37740.0001% mcap66.8% of flow
ShareKRX
DART:20260409001498·
Ideal exit: 4 Dec 2026 (T+270)
Executives●Other0DART
DART:20260323000316·details not loaded
Executives●Purchase23DART
€1,3595,994 shares@ €0.22670.0000% mcap10.4% of flow
ShareKRX
DART:20260313000274·
Ideal exit: 4 Dec 2026 (T+270)
8 of 8 declarations